These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2177025)

  • 21. Modification of DNA bases by anthralin and related compounds.
    Müller K; Leukel P; Mayer KK; Wiegrebe W
    Biochem Pharmacol; 1995 May; 49(11):1607-13. PubMed ID: 7786301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antipsoriatic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes.
    Fuchs J; Nitschmann WH; Packer L
    J Invest Dermatol; 1990 Jan; 94(1):71-6. PubMed ID: 2104916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes.
    Schmidt KN; Podda M; Packer L; Baeuerle PA
    J Immunol; 1996 Jun; 156(11):4514-9. PubMed ID: 8666828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 10-Phenylbutyryl-substituted anthracenones as inhibitors of keratinocyte growth and LTB(4) biosynthesis.
    Müller K; Breu K; Reindl H
    Eur J Med Chem; 2001 Feb; 36(2):179-84. PubMed ID: 11311748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Location of anthralin radical generation in mouse skin by UV-A irradiation: an estimation using microscopic EPR spectral-spatial imaging.
    Matsumoto K; Kawai S; Chignell CF; Utsumi H
    Magn Reson Med; 2006 Apr; 55(4):738-42. PubMed ID: 16528709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free radical intermediates produced by autoxidation of 1,8-dihydroxy-9-anthrone (dithranol) in pyridine.
    Martinmaa J; Vanhala L; Mustakallio KK
    Experientia; 1978 Jul; 34(7):872-3. PubMed ID: 208855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
    Peus D; Beyerle A; Vasa M; Pott M; Meves A; Pittelkow MR
    Exp Dermatol; 2004 Feb; 13(2):78-85. PubMed ID: 15009100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthralin: primary products of its redox reactions.
    Czerwinska M; Sikora A; Szajerski P; Zielonka J; Adamus J; Marcinek A; Piech K; Bednarek P; Bally T
    J Org Chem; 2006 Jul; 71(14):5312-9. PubMed ID: 16808521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of mouse epidermal 12-lipoxygenase by anthralin--implications for the role of oxygen radicals.
    Müller K; Gawlik I
    Biochem Pharmacol; 1996 May; 51(9):1173-9. PubMed ID: 8645340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dithranol-induced cytotoxicity in primary cultures of rat epidermal keratinocytes. I. The role of reactive oxygen species.
    Hsieh GC; Acosta D
    Toxicol Appl Pharmacol; 1991 Jan; 107(1):16-26. PubMed ID: 1846245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultraviolet radiation and nanoparticle induced intracellular free radicals generation measured in human keratinocytes by electron paramagnetic resonance spectroscopy.
    Rancan F; Nazemi B; Rautenberg S; Ryll M; Hadam S; Gao Q; Hackbarth S; Haag SF; Graf C; Rühl E; Blume-Peytavi U; Lademann J; Vogt A; Meinke MC
    Skin Res Technol; 2014 May; 20(2):182-93. PubMed ID: 24033792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTHQ (1-O-hexyl-2,3,5-trimethylhydroquinone), an anti-lipid-peroxidative compound: its chemical and biochemical characterizations.
    Hino T; Kawanishi S; Yasui H; Oka S; Sakurai H
    Biochim Biophys Acta; 1998 Sep; 1425(1):47-60. PubMed ID: 9813237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
    Wollina U; Klinger R; Wetzker R; Knopf B
    Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox cycling of phenol induces oxidative stress in human epidermal keratinocytes.
    Shvedova AA; Kommineni C; Jeffries BA; Castranova V; Tyurina YY; Tyurin VA; Serbinova EA; Fabisiak JP; Kagan VE
    J Invest Dermatol; 2000 Feb; 114(2):354-64. PubMed ID: 10651998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free radical formation in isolated murine keratinocytes treated with organic peroxides and its modulation by antioxidants.
    Timmins GS; Davies MJ
    Carcinogenesis; 1993 Aug; 14(8):1615-20. PubMed ID: 8394781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free radical scavenging and antioxidant activity of ascorbigen versus ascorbic acid: studies in vitro and in cultured human keratinocytes.
    Wagner AE; Huebbe P; Konishi T; Rahman MM; Nakahara M; Matsugo S; Rimbach G
    J Agric Food Chem; 2008 Dec; 56(24):11694-9. PubMed ID: 19053372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irritation, staining and antipsoriatic activity of 10-acyl analogues of anthralin.
    Mustakallio KK
    Br J Dermatol; 1981 Aug; 105 Suppl 20():23-7. PubMed ID: 6169361
    [No Abstract]   [Full Text] [Related]  

  • 38. An EPR method for estimating activity of antioxidants in mouse skin using an anthralin-derived radical model.
    Kawai S; Matsumoto K; Utsumi H
    Free Radic Res; 2010 Mar; 44(3):267-74. PubMed ID: 20001648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
    Van Duuren BL; Segal A; Tseng SS; Rusch GM; Loewengart G; Maté U; Roth D; Smith A; Melchionne S; Seidman I
    J Med Chem; 1978 Jan; 21(1):26-31. PubMed ID: 619147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro.
    Gottlieb AB; Khandke L; Krane JF; Staiano-Coico L; Ashinoff R; Krueger JG
    J Invest Dermatol; 1992 May; 98(5):680-5. PubMed ID: 1314863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.